Skip to main content

Fitbit cleared to launch new feature that could save lives

Fitbit has been given the green light for a new feature that will passively check for atrial fibrillation (AFib), a form of irregular heart rhythm.

Clearance for Fitbit’s new PPG (photoplethysmography) algorithm was granted by the U.S. Food and Drug Administration (FDA), paving the way for a new Irregular Heart Rhythm Notifications feature for certain Fitbit devices.

AFib is believed to affect around 33 million people globally, and individuals with the condition are at greater risk of suffering a potentially debilitating or life-threatening stroke.

As AFib usually occurs without warning, and sometimes without any noticeable symptoms, the condition can be hard to detect. However, Fitbit’s system will function around the clock, in the background, with the device’s sensors checking for any heartbeat abnormalities throughout the day and during sleep.

If the device detects anything that could be AFib, the Fitbit device will send a notification to the wearer. It should be emphasized that while the feature cannot be used to diagnose AFib, it can flag the possible presence of the condition.  In that case, anyone receiving a notification is encouraged to visit a doctor for further assessment.

The FDA clearance of Fitbit’s PPG-based algorithm means Fitbit now offers two ways to detect AFib, the other being Fitbit’s ECG (electrocardiogram) app that lets wearers proactively screen themselves for AFib. The new system, however, is a significant step forward as it allows for passive monitoring 24/7, increasing the chances of AFib detection should the wearer be living with the condition.

“We want to make AFib detection as accessible as possible to help reduce the risk of potentially life-threatening events — like stroke — and ultimately improve overall heart health for everyone,” Google-owned Fitbit said in a release announcing the new feature.

It added that the PPG-based algorithm and Irregular Heart Rhythm Notifications feature will be available “soon” to consumers in the U.S., across a range of its heart-rate-enabled devices.

In the same sector, Apple’s most recent smartwatches already include a similar AFib detection feature, but according to its website it only “occasionally” runs checks. It’s also possible to manually perform a check via an ECG feature, though as noted earlier, manual checks are not an ideal way to detect AFib.

Trevor Mogg
Contributing Editor
Not so many moons ago, Trevor moved from one tea-loving island nation that drives on the left (Britain) to another (Japan)…
AMD may be doing something unprecedented with Ryzen 9000
A render of a Ryzen 9000 CPU.

AMD's Ryzen 9000 processors are right around the corner, set to launch this month -- and we just got our first hint about how much they might cost. An early preorder from a Slovenian retailer revealed the pricing for all four Zen 5 desktop chips. On the whole, it's good news. AMD appears to be doing something that hardly ever happens by keeping the prices lower than they were at the launch of Zen 4. However, that doesn't mean that buying the new processors will save you money.

The preorders at Funtech, a Slovenian retailer, are now open, and this just might be the first place that's already selling Zen 5. The flagship Ryzen 9 9950X was listed at 660 euros ($708 at current exchange rates), followed by the Ryzen 9 9900X at 500 euros ($536), the Ryzen 7 9700X at 400 euros ($429), and lastly, the Ryzen 5 9600X, priced at 310 euros ($332).

Read more
Why Nvidia is about to get a huge edge over AMD
The Nvidia RTX 4080 Super on a pink background.

Micron has shared some performance figures for its next-gen graphics memory, and if these numbers turn out to be true, it could mean great things for upcoming graphics cards.

The company claims that its GDDR7 VRAM will offer up to 30% performance improvement in gaming scenarios, and this reportedly applies both to games that rely heavily on ray tracing and on pure rasterization. Will Nvidia's RTX 50-series, which is said to be using GDDR7 memory, turn out to be a bigger upgrade than expected?

Read more